Call for inquiry to cope with genomic breakthroughs 23 Nov 2011 0 comments Urgent changes to Australia's drug regulatory system are needed to cope with genomic discoveries that are 'fracturing' diseases into rarer subtypes.
Daily aspirin reduces colorectal cancers 2 Nov 2011 0 comments For the first time, a major RCT of aspirin for chemoprevention has demonstrated significant positive results, with findings sure to change the management of Lynch syndrome patients.
Faecal biomarkers reviewed 5 Oct 2011 0 comments Faecal biomarkers promise to significantly alter the way in which IBD is diagnosed and managed, Australian experts say.
Colon cancer diagnosed later in regional areas: study 21 Sep 2011 0 comments Colorectal cancer is more likely to be diagnosed at a late stage in people from regional areas than city dwellers, research shows.
Weight-loss advice flawed, experts say 31 Aug 2011 0 comments The benefits of calorie restriction have been “dramatically” overestimated based on official advice, Australian and international experts claim.
Chronic medications slip through cracks after hospital admission 24 Aug 2011 0 comments Patients with chronic diseases are at risk of having their long-term medications unintentionally discontinued after a hospital admission.
Reoperation rates could be used to assess surgeons and hospitals 17 Aug 2011 0 comments Colorectal surgeons’ performance could be partly assessed by reoperation rates, researchers say, as the literature on gaps in surgical quality mounts.
Changes to colonoscopy surveillance intervals: draft guidelines 10 Aug 2011 0 comments The Cancer Council Australia has released updated draft guidelines on surveillance colonoscopy which aim to reduce unnecessary examinations.
Old age no barrier to surgery for peritoneal carcinomatosis 3 Aug 2011 0 comments Old age alone should not be a barrier to surgery for colorectal cancer patients with peritoneal carcinomatosis, experts say.
Cancer risk greatest in patients without GORD symptoms 27 Jul 2011 0 comments Patients with medically-controlled gastro-oesophageal reflux disease and only mild or atypical symptoms have a higher risk of cancer than those with severe symptoms, a study finds.